advertisement
Hodrea J 21
Showing records 1 to 21 |
Display all abstracts from Hodrea J109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsTran MN
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsHodrea J
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsTran MN
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsHodrea J
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsMedveczki T
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsTran MN; Tran MN
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsMedveczki T
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsBesztercei B
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsBesztercei B; Besztercei B
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsBesztercei B
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsTorok G
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsMedveczki T; Medveczki T; Szabo AJ
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsSzabo AJ
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsSzabo AJ
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsSzabo AJ
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsŐrfi L
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsGasull X
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsKovacs I
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsKovacs I; Fekete A
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork CellsFekete A; Fekete A
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork CellsFekete A; Hodrea J; Hodrea J
Life (Basel, Switzerland) 2023; 13: